Showing results (971-980 of 2,831) with videos related to
Sort By:
Pageof 284
The Journal of Toxicological Sciences|March 22, 2017
Protective effect of SENP3-mediated SUMOylation against cadmium toxicityHongquan ZhuThe Journal of Toxicological Sciences|December 1, 1992
[A 52-week oral chronic toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethanesulfonate (FUT-187) in rats with a recovery period of 5 weeksS Okazaki, E Yamazaki, K Hatayama, et al.The Journal of Toxicological Sciences|December 1, 1992
[Reproductive and developmental toxicity studies of FUT-187. (III)--Postnatal study in rat F1 offspring from dams treated orally with FUT-187 during the period of fetal organogenesis]H Kawanishi, M Shiraishi, Y Igarashi, et al.The Journal of Toxicological Sciences|December 1, 1992
[A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in dogsK Watanabe, K Terazawa, M Terabayashi, et al.The Journal of Toxicological Sciences|November 1, 1992
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF during the period of fetal organogenesis in rats]H Taniguchi, Y Himeno, M Chono, et al.The Journal of Toxicological Sciences|November 1, 1992
[Mammalian toxicity of empenthrin (Vaporthrin, S-2852F)]H Kaneko, S Kawaguchi, Y Misaki, et al.The Journal of Toxicological Sciences|August 1, 1992
Toxicities of microencapsulated tribromomethane, dibromochloromethane and bromodichloromethane administered in the diet to Wistar rats for one monthY Aida, K Takada, O Uchida, et al.The Journal of Toxicological Sciences|March 17, 2004
Hepatocarcinogenesis by peroxisome proliferatorsTetsuya SugaThe Journal of Toxicological Sciences|November 1, 1992
Selective effect of chronic lead ingestion on tyrosine hydroxylase activity in brain regions of ratsK Chin, J H Ryu, J H Cheong, et al.The Journal of Toxicological Sciences|September 17, 2003
Animal models of human disease in drug safety assessmentUrs A BoelsterliPageof 284